Events8th International Electronic Conference on Medicinal Chemistry
Published
with-doi10.3390/ECMC2022-13425 (registering DOI)
This submission belongs to the session S4. Small molecules as drug candidates of the event 8th International Electronic Conference on Medicinal Chemistry
Published date
01 Nov, 2022
Academic Editor
author-avatarAlfredo Berzal-Herranz
Citation
Jovana Muškinja, Jovan Luković, Ivana Nikolić, Dejan Baskić, Zoran Ratković, Synthesis of some new N-acyl derivatives of ferrocenyl pyrazolines and investigation of their cytotoxic effect, in Proceedings of 8th International Electronic Conference on Medicinal Chemistry, 1 November–30 November 2022, MDPI: Basel, Switzerland, doi: 10.3390/ECMC2022-13425
Share
Email
Facebook
Twitter
LinkedIn

Synthesis of some new N-acyl derivatives of ferrocenyl pyrazolines and investigation of their cytotoxic effect

Jovan Luković 2
image
Zoran Ratković 5
1. Department of Sciences, Institute for Information Technologies, University of Kragujevac, Jovana Cvijića bb, 34000 Kragujevac, Serbia
2. Department of Biochemistry, Faculty of Medical Sciences, University of Kragujevac, Serbia
3. Department of Microbiology and Immunology, Faculty of Medical Sciences, University of Kragujevac, Svetozara Markovića 67, 34000 Kragujevac, Serbia;
4. Public Health Institute Kragujevac, Nikole Pašića 1, 34000 Kragujevac, Serbia
5. Department of Chemistry, Faculty of Science, University of Kragujevac, Radoja Domanovića 12, 34000 Kragujevac, Serbia
Abstract

For several years, ferrocene moiety represents a significant part of the structure of different biologically active compounds. Ferrocene is stable and non-toxic compound and as such very useful for various syntheses. The combination of pharmacologically active N-heterocycles with ferrocene mostly leads to a favorable change in biological properties in a huge number of drugs. Considering the importance of these properties, this article describes the synthesis and characterization of a new series of ferrocenyl pyrazolines in good yields. Screening of the new products in vitro against human cervical cancer cells (HeLa), human breast cancer cells (MDA-MB-231), human colon cancer cells (HCT-116), and human fibroblast (MRC-5, as control cells) by the MTT method was performed.

Keywords
cytotoxicity
ferrocene
pyrazolines
Poster
Electronic_Conference_on_Medicinal_Chemistry_PPT_template_file (1).pdf
Pd-catalyzed cycloaddition of bicyclic aziridine with isocyanates
Natural brewing peptides with enhanced inhibitory effect towards Angiotensin-Converting Enzyme